Patrick Griss
Co-Founder & Executive Partner @ Zühlke Ventures AG
Zürich, Switzerland
Patrick Griss is an Executive Partner of the Zühlke Group. In the past, he held Management Positions in the Life Science Industry as well as within the Product Engineering Division of Zühlke. He is member of the executive committee of Zühlke Ventures, a company fully owned by the Zühlke Group with the role to provide high-tech start-up companieswith smart and committed early phase funding. Dr. Patrick Griss also on the Advisory Committee at Empa's glaTec technology center.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries Patrick Griss invests in
Stages Patrick Griss invests in
Countries Patrick Griss invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 4 (80%)
- Medical Device 4 (80%)
- Health Diagnostics 2 (40%)
- Medical 1 (20%)
- Robotics 1 (20%)
Stage
- Series A 3 (60%)
- Seed 1 (20%)
Country
- Switzerland 3 (60%)
- Sweden 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Evismo provides diagnostics services in Switzerland | $1.1M / Seed / Sep 14, 2021 | ||
| Flow Neuroscience is a healthcare company that develops depression treatment devices that combines an easy-to-use brain stimulation headset with a personalized mobile app to target both the physical and behavioral elements of Major Depressive Disorder (MDD). The company's wearable stimulates a patient's left frontal lobe, the area of thebrain that has often lowered activity in people suffering from depression.Flow Neuroscience combines their wearable with a mobile app that nudges users to behaviors that will help lessen the effects of their depression, including exercise and regular sleeping patterns.The company's hope is to make available for the public a treatment that's currently only used in clinics specialized in brain stimulation. It also wants to make the treatment affordable enough to seriously challenge a dominant pharmaceuticals industry. | $10M / Series A / Aug 10, 2021 | ||
| Lunaphore Technologies S.A. is a Swiss company born with the vision of accelerating cancer research by bringing the field of spatial biology into mainstream laboratories. Lunaphore has developed its innovative spatial biology solutions based on an award-winning technology called FFeX (Fast Fluidic Exchange). Lunaphore has been recognized as one ofthe most innovative companies internationally. | $7M / Series A / Jul 15, 2017 | ||
| Distalmotion is a medical device company founded and based in Lausanne, Switzerland. Our mission is to remove the complexity out of robotic surgery in order to establish a new standard of care, where all patients in general surgery, gynecology and urology have access to best-in-class minimally invasive care. To do so, we have developed a surgicalrobot called Dexter. Designed, developed and manufactured in Switzerland, Dexter integrates the benefits of laparoscopy and robotics. Dexter combines the affordability of laparoscopy with the benefits of robotics through his novel, on-demand approach to robotic surgery. For further information, visit: dexter.surgery and follow us on LinkedIn and Twitter: @Distalmotion. | Series A / Aug 21, 2013 | ||
| See all 5 investments → | |||
Co-Investors
About Zühlke Ventures AG
Zühlke Ventures AG is a venture capital arm of Zühlke Technology Group AG specializing in financing of start-ups at an early stage and providing growth capital. It seeks to invest in the technology and medical devices companies. It typically invests in German-speaking Europe and Great Britain.
Zühlke Ventures AG Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Patrick Griss
Co-Founder & Executive Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Patrick Griss invest in?
Patrick Griss invests primarily in Health Care, Medical Device and Health Diagnostics startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Patrick Griss?
Public channels for Patrick Griss include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Patrick Griss last invest?
The most recent investment recorded for Patrick Griss closed in Sep 2021. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
